Prothena Corporation plc (PRTA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Prothena Corporation plc (PRTA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $502.6M, listed on NASDAQ, employing roughly 163 people, carrying a beta of -0.23 to the broader market. Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. Led by Gene G. Kinney, public since 2012-12-18.
Snapshot as of May 15, 2026.
- Spot Price
- $9.80
- Total OI
- 12.5K